DEVELOPMENT and VALIDATION of a SCORE to IDENTIFY OLDER ADULTS at RISK of ADVERSE DRUG REACTIONS: An international multicenter study.

Recruiting

• Conditions: risico-inschatting van risico op geneesmiddelbijwerkingen bij ouderen; adverse drug reactions; side effects of drugs

• Registration Number: NL-OMON32352
• Lead Sponsor: Erasmus MC, Universitair Medisch Centrum Rotterdam

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Last Update Posted: 6 May 2024

Recruitment & Eligibility

• Status: Recruiting
• Sex: Not specified
• Target Recruitment: 150

Inclusion Criteria

All patients aged 65 and over, admitted to the participating Departments during the study period will be enrolled and followed until discharge or death.

Exclusion Criteria

1.Age < 65 years old
2.Unwillingness to sign the written informed consent form
3.Oncology patients on anti-cancer drugs or on any other active treatment for their cancer, except those on tamoxifen
4.Patients transferred from other departments or from the Intensive Care Unit.

Study & Design

• Study Type: Observational non invasive
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
<p>The outcome of this study is the validation of the ADR-risk score. The score*s<br /><br>relationship with ADR will be assessed and Receiver Operating Characteristics<br /><br>(ROC) analyses will be performed to assess the ability of the score to predict<br /><br>ADR (sensitivity and specificity).</p><br>

Secondary Outcome Measures

Name	Time	Method
<p>NA</p><br>